Altamira Therapeutics (Altamira Therapeutics) ROE % Adjusted to Book Value : 191.22% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Altamira Therapeutics ROE % Adjusted to Book Value?

Altamira Therapeutics's ROE % for the quarter that ended in Dec. 2023 was 131.94%. Altamira Therapeutics's PB Ratio for the quarter that ended in Dec. 2023 was 0.69. Altamira Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 191.22%.

Altamira Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Altamira Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altamira Therapeutics ROE % Adjusted to Book Value Chart

Altamira Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-126.06

-46.70

-58.41

Altamira Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-64.24	-146.62	-	-	191.22

Competitive Comparison of Altamira Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Altamira Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Altamira Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altamira Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Altamira Therapeutics's ROE % Adjusted to Book Value falls into.

Altamira Therapeutics ROE % Adjusted to Book Value Calculation

Altamira Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	0.69
	=	0.00%

Altamira Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	131.94%	/	0.69
	=	191.22%

Altamira Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Altamira Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Altamira Therapeutics (Altamira Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altamira Therapeutics Ltd (NAS:CYTO) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Church Street, Clarendon House, Hamilton, BMU, HM11

Website

https://www.altamiratherapeutics.com

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens.